STEVE VELAZQUEZ: Open Payments
NPI 1912678624 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 23 payments from 8 companies in 2025. Trend: 2023 $1,263 · 2024 $824 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $320 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $197 |
| Teva Pharmaceuticals USA, Inc. | 3 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Janssen Pharmaceuticals, Inc | 2 | $59 |
| Lundbeck LLC | 1 | $32 |
| Alkermes, Inc. | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: COBENFY, CAPLYTA, AUSTEDO XR, INVEGA SUSTENNA, ABILIFY MAINTENA, REXULTI, ARISTADA, Auvelity.
Industry payments across NY — which companies pay providers there.
